About the Authors
- Isabel Paiva
-
Affiliations Molecular Oncology and Viral Pathology Group, CI-IPOP, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal, ICBAS, Abel Salazar Institute for the Biomedical Sciences, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050–313, Porto, Portugal
- Rui M. Gil da Costa
-
Affiliations LEPABE, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200–465, Porto, Portugal, Experimental Pathology and Therapeutics Group, CI-IPOP, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal
- Joana Ribeiro
-
Affiliations Molecular Oncology and Viral Pathology Group, CI-IPOP, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal, Virology Service, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal
- Hugo Sousa
-
Affiliations Molecular Oncology and Viral Pathology Group, CI-IPOP, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal, Virology Service, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal
- Margarida Bastos
-
Affiliation LEPABE, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias s/n, 4200–465, Porto, Portugal
- Ana Faustino Carlos Rocha
-
Affiliations Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro, UTAD, Quinta de Prados, 5001–911, Vila Real, Portugal, Experimental Pathology and Therapeutics Group, CI-IPOP, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal
- Paula A Oliveira
-
Affiliations Veterinary Sciences Department, University of Trás-os-Montes and Alto Douro, UTAD, Quinta de Prados, 5001–801, Vila Real, Portugal, Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro, UTAD, Quinta de Prados, 5001–911, Vila Real, Portugal
- Rui Medeiros
-
* E-mail: ruimedei@ipoporto.min-saude.pt
Affiliations Molecular Oncology and Viral Pathology Group, CI-IPOP, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal, ICBAS, Abel Salazar Institute for the Biomedical Sciences, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050–313, Porto, Portugal, Virology Service, Portuguese Institute of Oncology of Porto, Rua Dr. António Bernardino de Almeida, 4200–072 Porto, Portugal, CEBIMED, Faculty of Health Sciences of Fernando Pessoa University, Porto, Portugal, Portuguese League Against Cancer (Liga Portuguesa Contra o Cancro–Núcleo Regional do Norte), Estrada Interior da Circunvalação, n°6657, 4200–177 Porto, Portugal
Competing Interests
Rui Medeiros, Molecular Oncology and Viral Pathology Group, Portuguese Institute of Oncology Asoociate Professor, ICBAS, Instituto Ciências Biomédicas Abel Salazar (University of Porto) is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: IP RGC RM. Performed the experiments: IP JR HS RGC CL AFR. Analyzed the data: IP RGC RM. Contributed reagents/materials/analysis tools: MB PO RM. Wrote the paper: IP RGC HS RM.